Factors That Influence Endometriosis to Become a Malignancy: A Narrative Review

Factors That Influence Endometriosis to Become a Malignancy: A Narrative Review DOI: https://doi.org/10.33371/ijoc.v20i1.1431Keywords: endometriosis, endometriosis-related malignancy, endometriosis-related ovarian cancer, gynecologic cancerAbstract Endometriosis frequently affects women of reproductive age, and epidemiologic studies suggest it may be linked to an elevated risk of malignancy. Specific histopathological criteria characterise endometriosis-associated malignancy (EAM). Endometriosis-associated ovarian cancer (EAOC) accounts for about 80% of EAM occurrences, with the remaining 20% occurring outside the ovaries. Genetic mutations, including PTEN, ARID1A, and p53 alterations, are identified in endometriosis and EAM. Factors such as postmenopausal status, older age, and hypoestrogenic conditions have also been linked to higher risks of EAM and EAOC. Due to EAM's rarity, comprehensive data remains limited. This review examines current EAM research, focusing on EAOC and its clinical relevance.References Krawczyk N, Banys-Paluchowski M, Schmidt D, et al. Endometriosis-associated Malignancy. Geburtshilfe Frauenheilkd. 2016 Feb 29;76(2):176—81. Steinbuch S, Lüß A, Eltrop S, et al. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance. Int J Mol Sci. 2024 Apr 13;25(8):4306. Sun Y, Liu G. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity? J Cancer. 2021;12(22):6773—86. Jaiman S, Pochiraju M, Gundabattula S, et al. Malignant Transformation of Pelvic Endometriosis: Case Series and Review of the Literature. WilczyÅ„ski J, Paradowska E, WilczyÅ„ski M. High-Grade Serous Ovarian Cancer - A Risk Factor Puzzle and Screening Fugitive. Biomedicines. 2024 Jan 19;12(1):229. Mandai M, Yamaguchi K, Matsumura N, et al. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol. 2009 Oct;14(5):383—91. Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory Mediators and Pain in Endometriosis: A Systematic Review. Biomedicines. 2021 Jan 8;9(1):54. Suardika A, Pemayun TGA. New insights on the pathogenesis of endometriosis and novel non-surgical therapies. J Turk Ger Gynecol Assoc. 2018 Sep;19(3):158—64. Donnez J, Taylor H, Taylor R, et al. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomised clinical trial. Fertil Steril. 2020 Jul;114(1):44—55. Brichant G, Laraki I, Henry L, et al. New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments. Int J Mol Sci. 2021 Sep 28;22(19):10498. Li X, Yang L, Wang C, et al. Global burden and projected trends of ovarian cancer in older women: A GBD 2021 analysis. Tropical Medicine and Health. 2026 Mar 4. doi:10.1186/s41182-026-00933-7 Gadducci A, Zannoni G. Endometriosis-associated Extraovarian Malignancies: A Challenging Question for the Clinician and the Pathologist. Anticancer Res. 2020 May;40(5):2429—38. Robinson K, Menias C, Chen L, et al. Understanding the malignant transformation of endometriosis: imaging features with pathologic correlation. Abdom Radiol. 2020 Jun;45(6):1762—75. Yamaguchi K, Mandai M, Toyokuni S, et al. Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress. Clinical Cancer Research. 2008 Jan 2;14(1):32—40. doi:10.1158/1078-0432.CCR-07-1614 He J, Chang W, Feng C, et al. Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis. Int J Genomics. 2018;2018:1—13. Dawson A, Fernandez M, Anglesio M, et al. Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development. ecancermedicalscience. 2018 Jan 25;12:803. Tang L, Bian C. Research progress in endometriosis-associated ovarian cancer. Front Oncol. 2024 Apr 25;14:1381244. Iyshwarya B, Mohammed V, Veerabathiran R. Genetics of endometriosis and its association with ovarian cancer. Gynecol Obstet Clin Med. 2021 Dec;1(4):177—85. Mihailovici A, Rottenstreich M, Kovel S, et al. Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review. Medicine (Baltimore). 2017 Dec;96(49):e9136. Bas-Esteve E, Pérez-Arguedas M, Guarda-Muratori G, et al. Endometriosis and ovarian cancer: Their association and relationship. Eur J Obstet Gynecol Reprod Biol X. 2019 Jul;3:100053. SarrÃa-Santamera A, Khamitova Z, Gusmanov A, et al. History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer. J Pers Med. 2022 Aug 20;12(8):1337. Chen M, Zhang Y, Xu M, et al. Primary high-grade serous cancer arising from uterosacral ligament endometriosis: two case reports. J Int Med Res. 2022 Jul 14;50(7). Rasmussen C, Kjaer S, Albieri V, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-control studies. Am J Epidemiol. 2017 Jan 1;185(1):8—20. Carlson J, RÃ¥destad A, Söderberg-Naucler C, Rahbar A. Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival. Medicine (Baltimore). 2018 Jan 26;97(4):e9685. Iida Y, Okamoto A, Hollis R, et al. Clear cell carcinoma of the ovary: a clinical and molecular perspective. Int J Gynecol Cancer. 2021 Apr;31(4):605—16. Kim S, Lee J, Lee M, et al. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing. Gynecol Oncol. 2018 Feb;148(2):375—82. Zhu C, Xu Z, Zhang T, et al. Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma. J Cancer. 2021;12(8):2295—316. Testa U, Petrucci E, Pasquini L, et al. Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells. Medicines. 2018 Feb 1;5(1):16. Rahmanto YS, Shen W, Shi X, et al. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming. Nat Commun. 2020 Jun 1;11:2717. Honda M, Isono W, Tsuchiya A, et al. Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study. J Med Case Reports. 2019 Oct 22;13:314. Orezzoli JP, Russell AH, Oliva E, et al. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecologic Oncology. 2008 Sep 1;110(3):336—44. doi:10.1016/j.ygyno.2008.05.025 Zhou Y, Hua K. Ovarian endometriosis: risk factor analysis and prediction of malignant transformation. Menopausal Rev. 2018;17(1):43—8. Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: A Relevant Risk Factor for the Development of Cancer from Endometriosis. Gynecologic Oncology. 2000 Oct 1;79(1):18—22. doi:10.1006/gyno.2000.5905 Asaka S, Liu Y, Yu Z, et al. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis. Mod Pathol. 2023 Feb;36(2):100045. Li L, Yue P, Song Q, et al. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma. J Pathol. 2021 Jan;253(1):119—28. Hoadley K, Yau C, Hinoue T, et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018 Apr;173(2):291—304. Chen B, Zhao L, Yang R, Xu T. New insights about endometriosis-associated ovarian cancer: pathogenesis, risk factors, prediction and diagnosis and treatment. Front Oncol. 2024 Feb 7;14:1329133. Takagi H, Takata E, Sakamoto J, et al. Malignant Transformation of an Ovarian Endometrioma during Endometriosis Treatment: A Case Report. Case Rep Obstet Gynecol. 2018 Sep 4;2018:1—5. Nezhat F, Datta M, Hanson V, et al. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril. 2008 Nov;90(5):1559—70 Downloads Published How to Cite Issue Section License An author who publishes in the Indonesian Journal of Cancer agrees to the following terms: - The author retains the copyright and grants the journal the right of first publication of the work simultaneously licensed under the Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal - The author is able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book) with the acknowledgement of its initial publication in this journal. - The author is permitted and encouraged to post his/her work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of the published work. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.